Kingdon Capital Management »

Jasper Therapeutics shares owned by Kingdon Capital Management

Quarter-by-quarter ownership of Jasper Therapeutics shares owned by Kingdon Capital Management from 13F filings

Historical chart of Kingdon Capital Management investment in Jasper Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Jasper Therapeutics held by Kingdon Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jasper Therapeutics by Kingdon Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.8M 3.5M 0.79
2023-09-30 $2.1M 3.0M 0.70
2023-06-30 $4.2M 3.0M 1.37
2023-03-31 $5.5M 3.0M 1.81
2022-12-31 $261k 540k 0.48
2022-09-30 $426k 540k 0.79
2022-06-30 $1.0M 540k 1.93
2022-03-31 $1.9M 540k 3.55
2021-12-31 $4.2M 540k 7.85

More positions owned by Kingdon Capital Management

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Blackstone Group Inc Com Cl A Put Option (BX)
Sherwin-Williams Company Call Option (SHW)
Api Group Corp Com Stk (APG)
Catalent (CTLT)
Rapt Therapeutics (RAPT)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Teck Resources CL B (TECK)
Meta Platforms Cl A (META)
Ftai Aviation SHS (FTAI)
Union Pacific Corporation (UNP)
Molson Coors Beverage CL B (TAP)
Synchrony Financial Put Option (SYF)
Bank of America Corporation Call Option (BAC)
Dell Technologies CL C (DELL)

View all positions for Kingdon Capital Management

Top funds holding Jasper Therapeutics

Soleus Capital Management
Carlyle
Qiming U.S. Ventures Management
Octagon Capital Advisors
Vanguard Group
Opaleye Management
Kingdon Capital Management
Bank of America Corporation
Nantahala Capital Management
Landscape Capital Management
Sphera Funds Management
Mariner Wealth Advisors
Bank Of Montreal
Monaco Asset Management SAM
Citadel Advisors

View all funds holding Jasper Therapeutics